135 related articles for article (PubMed ID: 35445373)
1. Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein.
Zhou Y; Li Y; Zhang Y; Yi Z; Jiang M
Mol Cell Biochem; 2022 Sep; 477(9):2183-2191. PubMed ID: 35445373
[TBL] [Abstract][Full Text] [Related]
2. [Expression of long non-coding RNA MALAT1 in osteosarcoma and its effect on invasiveness and metastatic potential of osteosarcoma cells].
Zhang JH; Kang XH; Lu P; Miao ZH; Sun GS; Cao XJ; Cao F
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):561-5. PubMed ID: 27510783
[TBL] [Abstract][Full Text] [Related]
3. Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.
Feng Y; Sassi S; Shen JK; Yang X; Gao Y; Osaka E; Zhang J; Yang S; Yang C; Mankin HJ; Hornicek FJ; Duan Z
J Orthop Res; 2015 Feb; 33(2):199-207. PubMed ID: 25348612
[TBL] [Abstract][Full Text] [Related]
4. [Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro].
Wang J; Yin JQ; Jia Q; Shen JN; Huang G; Xie XB; Zou CY
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):734-8. PubMed ID: 21163061
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.
Yuan JM; Li XD; Liu ZY; Hou GQ; Kang JH; Huang DY; Du SX
Asian Pac J Cancer Prev; 2011; 12(12):3465-9. PubMed ID: 22471498
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
Duan Z; Lamendola DE; Penson RT; Kronish KM; Seiden MV
Cytokine; 2002 Mar; 17(5):234-42. PubMed ID: 12027404
[TBL] [Abstract][Full Text] [Related]
7. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
[TBL] [Abstract][Full Text] [Related]
8. [Empirical study of reverse effect on mediated multidrug resistance of U-2OS/ADM cells with curcumin in vitro].
Xiao Y; Wang W
Wei Sheng Yan Jiu; 2011 Jan; 40(1):103-6. PubMed ID: 21434326
[TBL] [Abstract][Full Text] [Related]
9. Xiao Jin Wan, a traditional Chinese herbal formula, inhibits proliferation via arresting cell cycle progression at the G2/M phase and promoting apoptosis via activating the mitochondrial‑dependent pathway in U-2OS human osteosarcoma cells.
Wu G; Chu J; Huang Z; Ye J; Chen P; Zheng C; Li X; Liu X; Wu M
Int J Oncol; 2013 Mar; 42(3):1070-80. PubMed ID: 23354363
[TBL] [Abstract][Full Text] [Related]
10. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ERICD interacts with ARID3A via E2F1 and regulates migration and proliferation of osteosarcoma cells.
Arman K; Saadat KASM; Igci YZ; Bozgeyik E; Ikeda MA; Cakmak EA; Arslan A
Cell Biol Int; 2020 Nov; 44(11):2263-2274. PubMed ID: 32749762
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b.
Sun Z; Zhang T; Chen B
Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707
[TBL] [Abstract][Full Text] [Related]
13. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end-products (RAGE) is overexpressed in human osteosarcoma and promotes the proliferation of osteosarcoma U-2OS cells in vitro.
Zhang Q; Jin Y; Zhao CF; Wang WJ; Liu GY
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323159
[TBL] [Abstract][Full Text] [Related]
15. MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells.
Liu C; Han X; Li B; Huang S; Zhou Z; Wang Z; Wang W
Cancer Manag Res; 2021; 13():6879-6889. PubMed ID: 34512027
[TBL] [Abstract][Full Text] [Related]
16. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of celastrol combined with cisplatin in enhancing the apoptosis of U-2OS osteosarcoma cells via the mitochondrial and endoplasmic reticulum pathways of apoptosis.
Wang Q; Yu X; Li F; Lv X; Fu X; Gu H; Liu H; Liu J; Dai M; Zhang B
Oncol Lett; 2019 Mar; 17(3):3305-3313. PubMed ID: 30867764
[TBL] [Abstract][Full Text] [Related]
18. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
19. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
[TBL] [Abstract][Full Text] [Related]
20. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
